Trials / Active Not Recruiting
Active Not RecruitingNCT07423663
Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications in Necrotic Teeth With Periapical Lesions
Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications in Necrotic Teeth With Periapical Lesions :A Randomized Controlled Clinical Trial
- Status
- Active Not Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Suez Canal University · Academic / Other
- Sex
- All
- Age
- 21 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
It is tackling antimicrobial resistance in endodontics, specifically comparing different intracanal medications used in root canal treatment. Given the growing concern over resistant bacterial strains, our study aims to evaluate the effectiveness of various medicaments in eliminating endodontic pathogens while minimising the risk of resistance development. By integrating microbiological analysis and clinical relevance, our research seeks to provide evidence-based recommendations for optimising intracanal disinfection protocols and improving treatment outcomes in endodontic infections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium Hydroxide Intracanal medication | Patients receiving CaOH (Metapaste) intracanal medication |
| DRUG | Calcium silicate based intracanal medication | Patients receiving Calcium silicate based (Bio-C Temp) intracanal medication |
| DRUG | Pectin | Patients receiving Pectin intracanal medication |
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2026-03-10
- Completion
- 2026-04-01
- First posted
- 2026-02-20
- Last updated
- 2026-02-20
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07423663. Inclusion in this directory is not an endorsement.